GA
Geller Advisors’s Eli Lilly LLY Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | $3.01M | Sell |
3,895
-131
| -3% | -$101K | 0.2% | 32 |
|
2024
Q3 | $3.57M | Sell |
4,026
-363
| -8% | -$322K | 0.25% | 28 |
|
2024
Q2 | $3.97M | Buy |
4,389
+196
| +5% | +$177K | 0.29% | 24 |
|
2024
Q1 | $3.26M | Buy |
4,193
+301
| +8% | +$234K | 0.26% | 27 |
|
2023
Q4 | $2.27M | Sell |
3,892
-11
| -0.3% | -$6.41K | 0.22% | 30 |
|
2023
Q3 | $2.1M | Buy |
3,903
+668
| +21% | +$359K | 0.24% | 27 |
|
2023
Q2 | $1.52M | Buy |
3,235
+424
| +15% | +$199K | 0.19% | 31 |
|
2023
Q1 | $965K | Buy |
2,811
+535
| +24% | +$184K | 0.14% | 32 |
|
2022
Q4 | $833K | Sell |
2,276
-348
| -13% | -$127K | 0.14% | 35 |
|
2022
Q3 | $848K | Buy |
2,624
+386
| +17% | +$125K | 0.18% | 25 |
|
2022
Q2 | $726K | Sell |
2,238
-8
| -0.4% | -$2.6K | 0.15% | 37 |
|
2022
Q1 | $643K | Buy |
2,246
+10
| +0.4% | +$2.86K | 0.12% | 48 |
|
2021
Q4 | $618K | Buy |
2,236
+71
| +3% | +$19.6K | 0.12% | 49 |
|
2021
Q3 | $500K | Sell |
2,165
-96
| -4% | -$22.2K | 0.11% | 56 |
|
2021
Q2 | $519K | Sell |
2,261
-98
| -4% | -$22.5K | 0.11% | 52 |
|
2021
Q1 | $441K | Buy |
2,359
+727
| +45% | +$136K | 0.1% | 55 |
|
2020
Q4 | $390K | Hold |
1,632
| – | – | 0.1% | 57 |
|
2020
Q3 | $242K | Sell |
1,632
-105
| -6% | -$15.6K | 0.07% | 70 |
|
2020
Q2 | $285K | Buy |
+1,737
| New | +$285K | 0.09% | 59 |
|